SmartSpace Software PLC (LON:SMRT) shares has rocketed after computer infrastructure giant Softcat said it would start reselling the AIM-listed company’s workplace contact tracing and social distancing software.
SmartSpace, which used to be called RedstoneConnect, and the FTSE 250 group have signed a distribution agreement for the latter to resell the Space Connect workspace management software, which is said to include “a range of solutions to support your office returning to the workplace” as part of its new Covid-19 functionality.
The ‘space management’ software specialist also provided a trading update that revealed an expanded relationship Standard Chartered bank, new contracts with an international law firm and an international news agency, plus news that that there was £1.7mln of net cash in the bank.
Shares in SmartSpace, having fallen more than 90% over the past three and half years to a low of 13p in April, were up 46% to 50.25p on Friday afternoon.
1.48pm: Physiomics loses fizz after confirming size of contract
In fact the contract had been trumpeted in advance by the AIM-listed company in May, June and earlier in July, contributing perhaps to the shares getting ahead of themselves.
Physiomics said it will be working with a new client, Japan’s Astellas Pharma, but could not disclose the precise value of the deal apart from saying it is “around 20%” of its last full year’s total income of £783,101.
11.28am: Pets at Home gets rewards for new customer loyalty
Revenues fell 13% decline in the first eight weeks of the quarter before recovering to a 12% jump in the subsequent eight weeks.
The results indicate that new customers won over lockdown are starting to become loyal, said analysts broker Peel Hunt (Read more here).
10.35am: Coro Energy sings lament for collapse of Italian deal
Shares in Coro, which is Italian for ‘choir’, fell 17% to 0.34p as Italian regulatory approval could not be obtained before the July 31 deadline to conclude the deal.
The AIM-listed oiler said it will continue to prioritise the sale of these non-core operations.
9.22am: Lansdowne jumps as Barryroe consortium members revealed
Lansdowne Oil & Gas PLC (LON:LOGP) shares spurted 16% higher to 1.25p in early trading on Friday after an encouraging update by project partners on the proposed farm out of the Barryroe oil and gas field, of which it owns a 20% interest.
The SpotOn Energy consortium, which has been revealed to include service providers Schlumberger and Maersk Drilling, will manage the development of Barryroe once the farm-out agreement is finalised.
Lansdowne chief executive Steve Boldy hailed the composition of the consortium and said: “With the consortium now in place, we will focus on concluding discussions with respect to a suitable work programme and the subsequent finalisation of commercial arrangements for the Barryroe development.”
Elsewhere, Thor Mining PLC (LON:THR)(ASX:THR) shot up 14% to 0.43p after revealing it has found visible gold from the latest phase of sample panning at its 100%-owned Pilbara goldfield tenements in Western Australia.
Among the highlights, 17 of the 32 stream sediment samples had visible gold in panning, while two of the 2019 sample sites had visible gold in multiple follow-up stream sediment samples.
Executive chairman Mick Billing said: “To find visible gold in multiple sites in very close proximity to previous gold samples is very encouraging.”
Proactive news headlines:
Tiziana Life Sciences PLC (LON:TILS, NASDAQ:TLSA) has submitted a patent application covering the potential use of nasally-administered and orally taken Foralumab for the treatment of COVID-19 either alone or in combination with other antiviral drugs. The methods of delivering the fully human anti-CD3 monoclonal antibody (mAb) could potentially modulate or stimulate the immune system to suppress cytokine storms and therefore reduce respiratory failure in coronavirus patients, the company said. Its researchers believe its combination with other anti-viral drugs could improve efficacy.
Thor Mining PLC (LON:THR) (ASX:THR) has revealed that there is visible gold from sample panning of the second phase of gold, nickel, and chromium geochemical sampling at the 100% owned Pilbara Goldfield tenements (E46/1262 and E46/1190) in Western Australia. Among the highlights, 17 of the 32 stream sediment samples had visible gold in panning, while two of the 2019 sample sites (19PST22 and 19PST32) had visible gold in multiple follow-up stream sediment samples, and samples 20PST04 and 20PST24 returned 13 and 11 grains respectively from panning. Mick Billing, Thor Mining’s executive chairman commented: “This appears to be a highly successful follow up, to the previous, very successful, sampling program.”
ReNeuron Group PLC (LON:RENE) has announced that the US Patent and Trademark office (USPTO) has completed its examination of the company’s patent application (14/379,239), entitled: “Phenotype profile of human retinal progenitor cells” and has issued a notification of allowance for the issuance of a patent. In a statement, the UK-based global leader in the development of cell-based therapeutics said the allowed patent protects the composition of the company’s hRPC cell-based therapeutic candidate for retinal diseases, cultured under specific conditions to enhance function and identifiable by the presence and absence of specific cell surface markers. This notification of allowance in the US adds further intellectual property protection to the hRPC technology, which already has patent protection in a number of other major territories including Europe, Japan and Australia, it added.
SkinBioTherapeutics PLC (LON:SBTX) has updated investors on the progress of its cosmetic skincare programme and a psoriasis food supplement trial. The AIM-listed firm said Sederma, its partner in the cosmetics programme and a division of Croda International PLC (LON:CRDA), has successfully replicated the lysate manufacturing process and achieved the same performance from the company’s SkinBiotix technology and is now working to validate a scale-up of the manufacturing process at different volume levels. Meanwhile, the firm said in light of current restrictions on non-coronavirus related human studies, it has established a protocol for its ‘ self-managed’ psoriasis food supplement trial and was proceeding with the study.
Impax Environmental Markets PLC (LON:IEX) revealed on Thursday that it is to pay a first interim dividend for the 2020 financial year of 1.3p per ordinary share, and said it is the intention of its board to declare a final, or second interim, dividend towards the end of the first quarter of 2021. In a statement released after the London market close, IEX said that in order to be equitable to all shareholders, and following a similar consideration of paying last year’s (single) dividend as an interim rather than a later final, the board has decided that henceforth it will declare an interim dividend at the half-year stage, with a second dividend payable after the year-end.
Oncimmune Holdings PLC (LON:ONC) has announced that The European Respiratory Journal – a leading lung disease-focused scientific publication and flagship journal of the European Respiratory Society – has published the peer-reviewed results from the Early detection of Cancer of the Lung Scotland (ECLS) trial. The trial was delivered by the Universities of Dundee and St Andrews with NHS Tayside, and co-funded by Oncimmune, the Scottish Chief Scientist Office and the Scottish Government. The leading global immunodiagnostics group said the paper titled ‘Earlier diagnosis of lung cancer in a randomised trial of an autoantibody blood test followed by imaging’ – which is now available online and will be replicated in print before Q3 2020 – evaluates the effectiveness of Oncimmune‘s EarlyCDT Lung test in reducing the incidence of patients presenting with late-stage lung cancer at diagnosis.
Collagen Solutions PLC (LON:COS) has reported that its year-to-date sales plus its confirmed order book are now over £4mln following the signing of two supply agreements in its first quarter. In an update on current trading accompanying results for the year ended March 31, 2020, the biomaterials and regenerative medicines firm also reported revenue of £900,000 for its first quarter, helped by a reduction in the impact of coronavirus experienced in the fourth quarter of the prior year, as well as a cash balance at the end of the period of £1.6mln. For the prior year, Collagen reported revenues of £4.46mln, down 1% year-on-year, alongside a pre-tax loss of £2.06mln compared to £1.79mln in the prior year.
MBH Corporation Plc (FRA:M8H) has expanded its construction arm with its fourth acquisition of 2020. GS Contracts (Joinery) Limited, a specialist in high-end hospitality and retail fit-out work, has joined the group for a consideration of £1.7mln in convertible notes and bonds. The payment includes the acquisition of a commercial property worth roughly £0.8mln as GS Contracts brings their own in-house production facilities.
NQ Minerals PLC (AQSE:NQMI) (OTCQB:NQMLF) (OTCQB:NQMIY) said it is “optimistic” for its prospects moving forward after reporting rising production from its Hellyer mine in the first part of 2020. In an outlook statement accompanying its results for the year ended December 31, 2019, the company reported that in the first quarter of 2020 it produced 8,127 tonnes of lead concentrate, up from 4,712 a year ago, while zinc concentrate rose to 4,609 tonnes from 3,015.
European Metals Holdings Limited (LON:EMH) (ASX:EMH) has highlighted “continued progress” at its Cinovec lithium and tin project in Czechia. In an update for the three months ended June 30, 2020, the AIM-listed firm said during the period a €29.1mln investment in Cinovec by conglomerate CEZ Group was completed and project work will commence immediately, while a preliminary mining permit for the project has also been granted relating to the eastern part of the deposit for eight years. The company is also in discussions with the Prague Stock Exchange regarding a proposed listing, adding that it has also arranged an interim funding facility to assist in financing new initiatives for ongoing operations.
Conroy Gold and Natural Resources PLC (LON:CGNR), the gold exploration and development company focused on Ireland and Finland, said it has received a notice to exercise warrants to subscribe for 1,358,333 ordinary shares at a price of 16p per ordinary share for which funds of £217,333 have been received by the company. The warrants were issued as part of the placing and subscription for new ordinary shares announced on February 18, 2020. The group added that proceeds from the exercise of the warrants will be used for general working capital purposes.
San Leon Energy PLC (LON:SLE), the independent oil and gas production, development and exploration company focused on Nigeria, has announced the appointment of Allenby Capital Limited as the company’s nominated adviser and joint broker with immediate effect. It also said that, following the acquisition of Whitman Howard Limited by Panmure Gordon & Co, it has appointed Panmure Gordon as its other joint broker with immediate effect.
Iofina PLC (LON:IOF), specialists in the exploration and production of iodine and manufacturers of specialty chemical products, has announced the launch of its new corporate website at www.iofina.com. The website will include current information for customers and investors, be mobile and tablet friendly, and will be continuously improved and updated.
Kodal Minerals PLC (LON:KOD), the mineral exploration and development company focused on its Bougouni Lithium Project in southern Mali, has announced that it’s annual general meeting (AGM) will be held at 12.00pm on August 27, 2020, at Prince Frederick House, 35-39 Maddox Street, London W15 2PP. As a consequence of the current measures implemented by the UK Government, shareholders will not be permitted to attend the AGM but are strongly encouraged to submit their votes by proxy as soon as possible. The company said it is intending to hold a webcast for shareholders after the AGM in the form of a presentation followed by Q&As. Further details will be announced in due course